Furthermore, HIF1α directly regulates NRP1 expression in cells exposed to a hypoxic microenvironment, suggesting a role for HIF1α-induced hypoxic responses in promoting lenvatinib resistance, particularly when the silencing of HIF1α enhances the anti-tumor effects of lenvatinib. The gene discussed is NRP1; the disease is neoplasm.